buy ur consumer staple stocks people,,p&g a dow leader 2day.........by the way,,,an excellent financial discussion broke out in the p-box with helmut leading the way,,its funny , not in a degrading way but u have people giving their 2 cents worth with very generic ideas and koaj is throwing around all these technical terms and theories that may have people scratching their heads,,,,investment forum catching on,,this is goin to be the place to be
I need all the advice I can get, I bought the financials last week. Hell, I'd even listen to what Dad has to say at this point
Quote Originally Posted by boiler-room:
buy ur consumer staple stocks people,,p&g a dow leader 2day.........by the way,,,an excellent financial discussion broke out in the p-box with helmut leading the way,,its funny , not in a degrading way but u have people giving their 2 cents worth with very generic ideas and koaj is throwing around all these technical terms and theories that may have people scratching their heads,,,,investment forum catching on,,this is goin to be the place to be
I need all the advice I can get, I bought the financials last week. Hell, I'd even listen to what Dad has to say at this point
No margin calls here, and I can hold, Vegas will just have to wait until fall. I am questioning my strategy however of buying the basket of financials via UYG as opposed to a few select companies like; JPM, WFC, and AXP.
Oh well, at this point I may pick-up a couple more shares next week to round out the lots, assuming we don't get a rally, and just ride it out.
I still think we see a rally, although from a much lower starting point, in the financials as the Fed gets brow beat'in into some major rate cuts, probably starting before the next meeting eom.
No margin calls here, and I can hold, Vegas will just have to wait until fall. I am questioning my strategy however of buying the basket of financials via UYG as opposed to a few select companies like; JPM, WFC, and AXP.
Oh well, at this point I may pick-up a couple more shares next week to round out the lots, assuming we don't get a rally, and just ride it out.
I still think we see a rally, although from a much lower starting point, in the financials as the Fed gets brow beat'in into some major rate cuts, probably starting before the next meeting eom.
Yeah, I remember. But when you go long in one of these "Ultra" ETF's, (that double daily performances), in this market, you start to question your thinking. But for that reason, I guess I need to stick with the Ultra ETF to catch that swing back up........if there ever is one.
Yeah, I remember. But when you go long in one of these "Ultra" ETF's, (that double daily performances), in this market, you start to question your thinking. But for that reason, I guess I need to stick with the Ultra ETF to catch that swing back up........if there ever is one.
Wouldn't shock me at all if someone starts a short covering bomb early this coming week.
My advice is to use it to close out current longs, and then look to fade this certain "sucker's rally" by shorting the SP. That's the only way to play a bear market.
Wouldn't shock me at all if someone starts a short covering bomb early this coming week.
My advice is to use it to close out current longs, and then look to fade this certain "sucker's rally" by shorting the SP. That's the only way to play a bear market.
Those April calls have to be doing quite well..stock has moved 3 pts since we talked about it.
The only risk/downside I see is if they dont get financing in place, they could lose a few contracts and that would NAIL the stock.
I think it is worth the risk, but you might want to check the volitility and when it peaks you might want to sell and roll out when the volatility is lower. (options speaking)
Regarding HOKU, do they not need to just get $35 million in financing? I know the corp paper markets are awful, but I sure hope they can find that relatively small amount from some source...given that they have inked $1.5 billion in deals with corps like Sanyo etc...
Quote Originally Posted by wallstreetcappers:
Those April calls have to be doing quite well..stock has moved 3 pts since we talked about it.
The only risk/downside I see is if they dont get financing in place, they could lose a few contracts and that would NAIL the stock.
I think it is worth the risk, but you might want to check the volitility and when it peaks you might want to sell and roll out when the volatility is lower. (options speaking)
Regarding HOKU, do they not need to just get $35 million in financing? I know the corp paper markets are awful, but I sure hope they can find that relatively small amount from some source...given that they have inked $1.5 billion in deals with corps like Sanyo etc...
Yes, for sure. I'd do it, too, but the overall market fundamentals are so gruesome going forward that I have promised myself to only do shorts for the time being.
CRDC is a damn good buy at this level, so long as you are in it for the long haul.
Stifler-
Yes, for sure. I'd do it, too, but the overall market fundamentals are so gruesome going forward that I have promised myself to only do shorts for the time being.
CRDC is a damn good buy at this level, so long as you are in it for the long haul.
I am quite sure they already have financing with ML in place, but I am not sure if this is somthing different or not.
It will either be a huge hit or a huge bomb. The market is drastically discounting their future prospects to put it lightly.
That fact really spooks me,but not enough to bail out of the options . The question is, what is the reasoning behind such a discounting??I have read all I can find on them, and nothing really has stood out. Maybe I need to go back over it again...
Quote Originally Posted by wallstreetcappers:
Vermeer,
I am quite sure they already have financing with ML in place, but I am not sure if this is somthing different or not.
It will either be a huge hit or a huge bomb. The market is drastically discounting their future prospects to put it lightly.
That fact really spooks me,but not enough to bail out of the options . The question is, what is the reasoning behind such a discounting??I have read all I can find on them, and nothing really has stood out. Maybe I need to go back over it again...
Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones
-
Cardica Attains Fourth Milestone in Vascular Closure Device
Collaboration Agreement and Completes Initial Development Milestone for
Device to Repair Heart Defects -
January 07, 2008: 08:00 AM EST
REDWOOD CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Cardica,
Inc. today announced that it has received nearly $2 million in payments
from Cook Medical (Cook) for the achievement of significant milestones
pursuant to its development agreements with Cook. Cardica received the
fourth and final milestone payment of $500,000 for the delivery of the
Cook Vascular Closure Device (CVCD), an innovative automated system
designed to close access openings in femoral arteries after
interventional vascular procedures. Cook also paid $1.3 million to
Cardica for the successful completion of the first phase of design and
development of a specialized device designed to close holes in the
heart known as patent foramen ovales (PFO), genetic heart defects.
Cardica also received a payment of $180,000 from Cook for the
initial purchase of parts to build a specific number of these vascular
closure devices for commercial use.
"We believe the novel design and unique features of the Cook
Vascular Access Closure Device address the large and growing market
need for next-generation vascular closure devices. We expect to
introduce the CVCD in a limited number of sites in Europe early this
year," said Brian Bates, senior vice president of business development
for Cook. "Moreover, Cardica has made excellent progress with the
design of an innovative device to close PFOs. We are looking forward to
working together with Cardica on the next phase of development and the
initial pre-clinical testing of this ground-breaking device."
Under the agreement for the CVCD, Cardica has received a total of
$2.0 million in milestone payments and has expanded this collaboration
to include a second product in the vascular closure device product
line. Similarly, under the agreement for the PFO closure device,
Cardica has received to date $2.15 million in fees and milestone
payments and may receive an additional approximately $1.4 million in
development milestone payments beyond the $1.3 million announced today.
With both products, Cardica is also entitled to receive royalties on
any future worldwide sales by Cook, and Cook has exclusive worldwide
commercialization and marketing rights.
"We are excited that our work with Cook is serving to advance new
solutions for closure devices in the areas of vascular access and PFOs.
The rapid advancement of both these programs is a testament to the
excellent collaborative relationship we have developed with Cook and
the true partnership we have together," said Bernard A. Hausen, M.D.,
Ph.D., president and chief executive officer of Cardica.
The CVCD Advantage for Interventional Procedures
An estimated 8.5 million diagnostic and interventional
catheterization procedures were performed worldwide in 2006, all of
which required access site closure either by manual compression or
alternative vascular closure devices and techniques. In approximately
45 percent of these cases, a closure device was used, and that number
is steadily increasing. The worldwide market for femoral artery closure
devices alone is estimated to be more than $750 million in 2008.
The potential advantages of the closure devices developed by
Cardica and Cook include a simple user interface, the ability to place
it through the same introducer sheath used for the interventional
procedure for greater convenience and speed, scalability and lower cost
of goods.
About Patent Foramen Ovale
A patent foramen ovale (PFO) is a congenital heart defect. During
fetal development, the heart's two upper chambers are connected by a
hole that allows blood to be diverted away from the lungs because they
are not yet developed. This hole, called the foramen ovale, is
necessary for healthy fetal development and closes naturally in
approximately 80 percent of the general population by the age of two.
When it remains open after this period, it is said to be patent, or
open. PFO is believed to be present in approximately 15 to 20 percent
of the general population.
People with a PFO often are asymptomatic, but are at greater risk
for stroke and systemic embolism because of the potential formation of
blood clots. With larger PFOs, patients may experience labored
breathing, recurrent respiratory infections and even heart failure or
death. Today, PFOs are treated by the use of a blood thinning
medication (aspirin or warfarin) to prevent blood clots, or the PFO is
closed through open heart surgery or transcatheter closure procedure.
About Cook Medical
Cook Medical was the first company to introduce interventional
devices in the United States. Today, the company integrates device
design, biopharma, gene and cell therapy and biotech to enhance patient
safety and improve clinical outcomes in the fields of aortic
intervention; cardiology; critical care medicine; gastroenterology;
radiology, peripheral vascular, bone access and oncology; surgery and
soft tissue repair; urology; and assisted reproductive technology,
gynecology and high-risk obstetrics. Cook won the prestigious Medical
Device Manufacturer of the Year Award for 2006 from Medical Device
& Diagnostic Industry magazine. For more information, visit
https://www.cookmedical.com.
About Cardica
Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones
-
Cardica Attains Fourth Milestone in Vascular Closure Device
Collaboration Agreement and Completes Initial Development Milestone for
Device to Repair Heart Defects -
January 07, 2008: 08:00 AM EST
REDWOOD CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Cardica,
Inc. today announced that it has received nearly $2 million in payments
from Cook Medical (Cook) for the achievement of significant milestones
pursuant to its development agreements with Cook. Cardica received the
fourth and final milestone payment of $500,000 for the delivery of the
Cook Vascular Closure Device (CVCD), an innovative automated system
designed to close access openings in femoral arteries after
interventional vascular procedures. Cook also paid $1.3 million to
Cardica for the successful completion of the first phase of design and
development of a specialized device designed to close holes in the
heart known as patent foramen ovales (PFO), genetic heart defects.
Cardica also received a payment of $180,000 from Cook for the
initial purchase of parts to build a specific number of these vascular
closure devices for commercial use.
"We believe the novel design and unique features of the Cook
Vascular Access Closure Device address the large and growing market
need for next-generation vascular closure devices. We expect to
introduce the CVCD in a limited number of sites in Europe early this
year," said Brian Bates, senior vice president of business development
for Cook. "Moreover, Cardica has made excellent progress with the
design of an innovative device to close PFOs. We are looking forward to
working together with Cardica on the next phase of development and the
initial pre-clinical testing of this ground-breaking device."
Under the agreement for the CVCD, Cardica has received a total of
$2.0 million in milestone payments and has expanded this collaboration
to include a second product in the vascular closure device product
line. Similarly, under the agreement for the PFO closure device,
Cardica has received to date $2.15 million in fees and milestone
payments and may receive an additional approximately $1.4 million in
development milestone payments beyond the $1.3 million announced today.
With both products, Cardica is also entitled to receive royalties on
any future worldwide sales by Cook, and Cook has exclusive worldwide
commercialization and marketing rights.
"We are excited that our work with Cook is serving to advance new
solutions for closure devices in the areas of vascular access and PFOs.
The rapid advancement of both these programs is a testament to the
excellent collaborative relationship we have developed with Cook and
the true partnership we have together," said Bernard A. Hausen, M.D.,
Ph.D., president and chief executive officer of Cardica.
The CVCD Advantage for Interventional Procedures
An estimated 8.5 million diagnostic and interventional
catheterization procedures were performed worldwide in 2006, all of
which required access site closure either by manual compression or
alternative vascular closure devices and techniques. In approximately
45 percent of these cases, a closure device was used, and that number
is steadily increasing. The worldwide market for femoral artery closure
devices alone is estimated to be more than $750 million in 2008.
The potential advantages of the closure devices developed by
Cardica and Cook include a simple user interface, the ability to place
it through the same introducer sheath used for the interventional
procedure for greater convenience and speed, scalability and lower cost
of goods.
About Patent Foramen Ovale
A patent foramen ovale (PFO) is a congenital heart defect. During
fetal development, the heart's two upper chambers are connected by a
hole that allows blood to be diverted away from the lungs because they
are not yet developed. This hole, called the foramen ovale, is
necessary for healthy fetal development and closes naturally in
approximately 80 percent of the general population by the age of two.
When it remains open after this period, it is said to be patent, or
open. PFO is believed to be present in approximately 15 to 20 percent
of the general population.
People with a PFO often are asymptomatic, but are at greater risk
for stroke and systemic embolism because of the potential formation of
blood clots. With larger PFOs, patients may experience labored
breathing, recurrent respiratory infections and even heart failure or
death. Today, PFOs are treated by the use of a blood thinning
medication (aspirin or warfarin) to prevent blood clots, or the PFO is
closed through open heart surgery or transcatheter closure procedure.
About Cook Medical
Cook Medical was the first company to introduce interventional
devices in the United States. Today, the company integrates device
design, biopharma, gene and cell therapy and biotech to enhance patient
safety and improve clinical outcomes in the fields of aortic
intervention; cardiology; critical care medicine; gastroenterology;
radiology, peripheral vascular, bone access and oncology; surgery and
soft tissue repair; urology; and assisted reproductive technology,
gynecology and high-risk obstetrics. Cook won the prestigious Medical
Device Manufacturer of the Year Award for 2006 from Medical Device
& Diagnostic Industry magazine. For more information, visit
https://www.cookmedical.com.
The only thing that is going to (only temporarily) boost this market is a large Fed rate cut and by the time they do that it will be fully priced in anyway.A pretty belated reaction by the market to the obvious thought that the housing meltdown means recession. Pretty simple thought.
Until the financials recover, (and it will be over a year from now I think), this market will go nowhere...maybe sideways at best, further down more likely.
To me this Fed has little left in the way of ammo. They might have lessened the downturn had they used their limited weaponry earlier, but they did not.
Governernment spending, never under control, will only increase under a Democratic regime, as will taxes. Hardly a recipe for recovery.
The only thing that is going to (only temporarily) boost this market is a large Fed rate cut and by the time they do that it will be fully priced in anyway.A pretty belated reaction by the market to the obvious thought that the housing meltdown means recession. Pretty simple thought.
Until the financials recover, (and it will be over a year from now I think), this market will go nowhere...maybe sideways at best, further down more likely.
To me this Fed has little left in the way of ammo. They might have lessened the downturn had they used their limited weaponry earlier, but they did not.
Governernment spending, never under control, will only increase under a Democratic regime, as will taxes. Hardly a recipe for recovery.
You guys are so bearish. I'm actually not. Think the valuations out there are pretty reasonable for the most part. Think a (mild) recession is priced in at this point in large part. If the economy recovers or the recession is mild or ends quick the market will snap back pretty quickly and we'll be at new highs again. Market looks ahead 6 months and I think the 2nd half of the year will be good to the market with new highs late in the year. Just my opinion. I could be wrong.
You guys are so bearish. I'm actually not. Think the valuations out there are pretty reasonable for the most part. Think a (mild) recession is priced in at this point in large part. If the economy recovers or the recession is mild or ends quick the market will snap back pretty quickly and we'll be at new highs again. Market looks ahead 6 months and I think the 2nd half of the year will be good to the market with new highs late in the year. Just my opinion. I could be wrong.
does depeche work for cnbc?......just kiddin bro,,i hope ur right ,,,,i think u will see continued volitility which is not good,,the market hates the unknown and uncertain,,which until this all shakes out is what u got....think of all the money that was taken out of the equity in peoples houses over the last 4 years,,most of that money,,stupidly for them,was used to spend,,tvs , cars , new kithens and bathrooms in the house, vacations ,,,now there is no more treating ur house like an atm,,thereforwe the consumer spending goes way down becuase there is no more to spend, it has to be felt somewhere,billions of dollares not being spent by consumers ,,,,,,,,not to mention if the numbers are right , the amount of people who are going to lose their houses to foreclosure,that has an effect,,now take into account the buisnesses that are involved in these sectors,,homebuilders ,mortgage companies and banks who lend the money that is not beimg repaid,,investment firms who packaged these mortgages as investments that are getting smoked,,,,,all not good,,,now if you will excuse me,,i must go to lunch
does depeche work for cnbc?......just kiddin bro,,i hope ur right ,,,,i think u will see continued volitility which is not good,,the market hates the unknown and uncertain,,which until this all shakes out is what u got....think of all the money that was taken out of the equity in peoples houses over the last 4 years,,most of that money,,stupidly for them,was used to spend,,tvs , cars , new kithens and bathrooms in the house, vacations ,,,now there is no more treating ur house like an atm,,thereforwe the consumer spending goes way down becuase there is no more to spend, it has to be felt somewhere,billions of dollares not being spent by consumers ,,,,,,,,not to mention if the numbers are right , the amount of people who are going to lose their houses to foreclosure,that has an effect,,now take into account the buisnesses that are involved in these sectors,,homebuilders ,mortgage companies and banks who lend the money that is not beimg repaid,,investment firms who packaged these mortgages as investments that are getting smoked,,,,,all not good,,,now if you will excuse me,,i must go to lunch
Good points. We'll see, when it comes down to it it's really about corporate earnings going forward. If these things impact the bottom line more than expected in future quarters then the market falls further. There certainly are risks out there and it's probably not a time to be fully invested. But at the same time, down markets are not the time historically to be on the sidelines.
Good points. We'll see, when it comes down to it it's really about corporate earnings going forward. If these things impact the bottom line more than expected in future quarters then the market falls further. There certainly are risks out there and it's probably not a time to be fully invested. But at the same time, down markets are not the time historically to be on the sidelines.
Haven't posted in a while, hope everyone had a good holiday and new year. I've got some fresh cash now and i'm looking for some good ideas. I'm not to bullish right now, but would like to get a couple longs and a couple inverse ETFs soon. I'm looking at starting a position in FXP tomorrow after the drop today. I'm considering a small CRDC position as well.
WallStreetCappers, what do you think of HANS these days?
I haven't been following everyone's picks lately. what are everyone's favorite long or short positions?
Haven't posted in a while, hope everyone had a good holiday and new year. I've got some fresh cash now and i'm looking for some good ideas. I'm not to bullish right now, but would like to get a couple longs and a couple inverse ETFs soon. I'm looking at starting a position in FXP tomorrow after the drop today. I'm considering a small CRDC position as well.
WallStreetCappers, what do you think of HANS these days?
I haven't been following everyone's picks lately. what are everyone's favorite long or short positions?
The stock market is oversold short-term, which invites the
potential for a spectacular "clearing rally" of the typical variety –
fast, furious, and prone to failure. While such an upward spike might
be embraced as some sort of message that the market has "fully
discounted" negative conditions and mark a successful "test" of prior
lows, the data suggest that underlying market and economic conditions
are rapidly deteriorating. In that context, a spectacular short-term
rally (particularly a one-day barn burner) could provide a setup for
concerted selling. As usual, I have no intention of
encouraging investors to depart from well constructed investment plans,
but investors should recognize that a 30% market decline is only a standard run-of-the-mill
bear. It's a good idea to evaluate your investment portfolio to ensure
you could tolerate that outcome, should it occur, without abandoning
your discipline.
Something to consider from a newsletter...
The stock market is oversold short-term, which invites the
potential for a spectacular "clearing rally" of the typical variety –
fast, furious, and prone to failure. While such an upward spike might
be embraced as some sort of message that the market has "fully
discounted" negative conditions and mark a successful "test" of prior
lows, the data suggest that underlying market and economic conditions
are rapidly deteriorating. In that context, a spectacular short-term
rally (particularly a one-day barn burner) could provide a setup for
concerted selling. As usual, I have no intention of
encouraging investors to depart from well constructed investment plans,
but investors should recognize that a 30% market decline is only a standard run-of-the-mill
bear. It's a good idea to evaluate your investment portfolio to ensure
you could tolerate that outcome, should it occur, without abandoning
your discipline.
Hot Forum Topics
